HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea

AIDS Research and Human Retroviruses

Volumn 26, Issue 9, 2010, Pages 1027-1031

  Djoko, Cyrille F ^a,b   Wolfe, Nathan D ^b,c   Vidal, Nicole ^d   Tamoufe, Ubald ^b   Montavon, Celine ^d   Lebreton, Matthew ^b   Pike, Brian L ^b   Fair, Joseph ^b   Mbacham, Wilfred F ^a   Benito, Alogos ^e   Rimoin, Anne W ^f   Saylors, Karen ^b   Mpoudi Ngole, Eitel ^g   Grillo, Michael P ^h   Peeters, Martine ^d  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Global Viral Forecasting Initiative (GVFI)   (United States)

^c STANFORD UNIVERSITY   (United States)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^e Division of Military Health   (Guinea)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Institute of Medical Research and Medicinal Plant Studies Yaounde   (Cameroon)

^h ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL RESISTANCE; ARTICLE; GENE MUTATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; GUINEA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS STRAIN; ADOLESCENT; ADULT; DRUG EFFECTS; EQUATORIAL GUINEA; FEMALE; GENETICS; HIV INFECTIONS; MALE; MIDDLE AGED; MOLECULAR GENETICS; PHYLOGENY; SEQUENCE ANALYSIS; SOLDIER; VIROLOGY; YOUNG ADULT;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; POL PROTEIN;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; EQUATORIAL GUINEA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MILITARY PERSONNEL; MOLECULAR SEQUENCE DATA; PHYLOGENY; POL GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, PROTEIN; YOUNG ADULT;

EID: 77956379044     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0046     Document Type: Article

References (21)

1. Hahn BH, Shaw GM, De Cock KM, and Sharp PM: AIDS as a zoonosis: Scientific and public health implications. Science 2000;287(5453):607-614.
2. Plantier JC, Leoz M, Dickerson JE, et al.: A new human immunodeficiency virus derived from gorillas. Nat Med 2009;15:871-872.
3. Peeters M, Toure-Kane C, and Nkengasong JN: Genetic diversity of HIV in Africa: Impact on diagnosis, treatment, vaccine development and trials. AIDS 2003;17(18):2547-2560.
4. McCutchan FE: Understanding the genetic diversity of HIV-1. AIDS 2000;14(Suppl 3):S31-44.
5. Vidal N, Peeters M, Mulanga-Kabeya C, et al.: Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. J Virol 2000;74(22):10498-10507.
6. Worobey M, Gemme M, Teuwen DE, et al.: Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 2008;455:661-665.
7. Ortiz M, Sanchez I, Gonzalez MP, et al.: Molecular epidemiology of HIV type 1 subtypes in Equatorial Guinea. AIDS Res Hum Retroviruses 2001;17(9):851-855.
8. Ortiz M, Munoz L, Bernal A, et al.: Molecular characterization of non-B HIV type 1 subtypes from Africa in Spain. AIDS Res Hum Retroviruses 2000;16(18):1967-1971.
9. Toro C, Jimenez V, Rodŕguez C, et al.: Molecular and epidemiological characteristics of blood-borne virus infections among recent immigrants in Spain. J Med Virol 2006;78: 1599-1608.
10. Holgún A, Rodés B, and Soriano V: Protease gene analysis of HIV type 1 non-B subtypes in Spain. AIDS Res Hum Retroviruses 2000;16(14):1395-1403.
11. Vergne L, Bourgeois A, Mpoudi-Ngole E, et al.: Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02-AG variant and disease stage. Virology 2003;17(9):851-855.
12. Vergne L, Peeters M, Mpoudi-Ngole E, et al.: Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: Evidence of many minor drug resistance mutations in treatment-naive patients. J Clin Microbiol 2000;38(11): 3919-3925.
13. Peeters M, Courgnaud V, Abela B, et al.: Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg Infect Dis 2002;8(5):451-457.
14. Vidal N, Bazepeo SE, Mulanga C, Delaporte E, and Peeters M: Genetic characterization of eight full-length HIV type 1 genomes from the Democratic Republic of Congo (DRC) reveal a new subsubtype, A5, in the A radiation that predominates in the recombinant structure of CRF26-A5U. AIDS Res Hum Retroviruses 2009;25(8):823-832.
15. Delgado E, Thomson MM, Villahermosa ML, et al.: Identification of a newly characterized HIV-1 BG intersubtype recombinant form in Galicia, Spain, which exhibits a pseudotype-like virion structure. J AIDS 2002;29:536-543.
16. Bennett DE, Camacho RJ, Otelea D et al.: Drug resistance mutations for surveillance of transmitted HIV-1 drug resistance: 2009 update. Plos One 2009;4 (3):e4724.
17. Heredia A, Vallejo A, Soriano V, et al.: Evidence of HIV-2 infection in Equatorial Guinea (central Africa): Partial genetic analysis of a B subtype virus. AIDS Res Hum Retroviruses 1997;13(5):439-440.
18. Brennan CA, Bodelle P, Coffey R, et al.: The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004. J AIDS 2008;49(4):432-439.
19. Meloni ST, Sankalé JL, Hamel DJ, et al.: Molecular epidemiology of human immunodeficiency virus type 1 subsubtype A3 in Senegal from 1988 to 2001. J Virol 2004; 78(22):12455-12461.
20. Niama FR, Toure-Kane C, Vidal N, et al.: HIV-1 subtypes and recombinants in the Republic of Congo. Infect Genet Evol 2006;6:337-343.
21. Bennett DE, Myatt M, Bertognolio S, et al.: Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antiviral Ther 2008;13(Suppl 2):25-36.